Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa (Q37179716)

18 August 2017

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa (English)

1 reference

18 August 2017

anti-retroviral agent

0 references

0 references

3

Linda-Gail Bekker

1 reference

18 August 2017

Richard Kaplan

4

0 references

Catherine Orrell

object named as

Catherine Orrell

series ordinal

6

0 references

Stephen Lawn

series ordinal

1

object named as

Stephen D Lawn

1 reference

18 August 2017

7

Robin Wood

1 reference

18 August 2017

2

Francesca Little

1 reference

18 August 2017

Elizabeth Campbel

5

1 reference

PMCID

3776050

18 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

18 August 2017

1 reference

18 August 2017

23

1 reference

18 August 2017

3

1 reference

18 August 2017

335-342

1 reference

Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Immunological recovery and antiretroviral therapy in HIV-1 infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Mortality and progression to AIDS after starting highly active antiretroviral therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776050

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19114870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19114870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E328321823F

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

3776050